Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kazuma Nagata

Showing results (41-50 of 75) with videos related to

Pageof 8
Sort By:
Sleep|September 19, 2025
Associations among nonrestorative sleep status, sleep apnea syndrome, and major adverse cardiac and cerebrovascular events: Health check-up and claims data in JapanNaomi Takahashi, Yoshimitsu Takahashi, Kimihiko Murase, et al.
Japanese Journal of Clinical Oncology|September 23, 2024
Phase II study of carboplatin plus weekly paclitaxel with bevacizumab for non-squamous, non-small cell lung cancer with idiopathic interstitial pneumonia (Hanshin Cancer Group IP002)Nobuyuki Katakami, Kazuma Nagata, Akiyoshi Nakakura, et al.
Experimental and Therapeutic Medicine|December 2, 2015
Evaluation of discomfort and tolerability to bronchoscopy according to different sedation procedures with midazolamTakeshi Matsumoto, Kojiro Otsuka, Ryoji Kato, et al.
Respirology (Carlton, Vic.)|November 21, 2012
Serum procalcitonin is a valuable diagnostic marker in acute exacerbation of interstitial pneumoniaKazuma Nagata, Keisuke Tomii, Kojiro Otsuka, et al.
Anticancer Research|March 2, 2018
Reduced Tumour Proportion Scores for Programmed Cell Death Ligand 1 in Stored Paraffin Tissue SectionsYuki Sato, Daichi Fujimoto, Keiichiro Uehara, et al.
Plos One|December 23, 2016
Characteristics and Prognostic Impact of Pneumonitis during Systemic Anti-Cancer Therapy in Patients with Advanced Non-Small-Cell Lung CancerDaichi Fujimoto, Ryoji Kato, Takeshi Morimoto, et al.
Respiratory Investigation|June 26, 2025
Association between nonrestorative sleep status and sleep apnea syndrome: A cross-sectional and longitudinal study using health check-up and health insurance claims data in JapanNaomi Takahashi, Yoshimitsu Takahashi, Kimihiko Murase, et al.
Anticancer Research|October 28, 2015
Second-line Chemotherapy for Patients with Small Cell Lung Cancer and Interstitial Lung DiseaseDaichi Fujimoto, Ryoko Shimizu, Ryoji Kato, et al.
Clinical Lung Cancer|May 31, 2018
Programmed Cell Death Ligand 1 Expression in Non-Small-cell Lung Cancer Patients With Interstitial Lung Disease: A Matched Case-control StudyDaichi Fujimoto, Yuki Sato, Takeshi Morimoto, et al.
Cancer Chemotherapy and Pharmacology|September 24, 2014
The safety and efficacy of paclitaxel and carboplatin with or without bevacizumab for treating patients with advanced nonsquamous non-small cell lung cancer with interstitial lung diseaseRyoko Shimizu, Daichi Fujimoto, Ryoji Kato, et al.
Pageof 8

Showing results (41-50 of 75) with videos related to

Sort By:
Pageof 8
Sleep|September 19, 2025
Associations among nonrestorative sleep status, sleep apnea syndrome, and major adverse cardiac and cerebrovascular events: Health check-up and claims data in JapanNaomi Takahashi, Yoshimitsu Takahashi, Kimihiko Murase, et al.
Japanese Journal of Clinical Oncology|September 23, 2024
Phase II study of carboplatin plus weekly paclitaxel with bevacizumab for non-squamous, non-small cell lung cancer with idiopathic interstitial pneumonia (Hanshin Cancer Group IP002)Nobuyuki Katakami, Kazuma Nagata, Akiyoshi Nakakura, et al.
Experimental and Therapeutic Medicine|December 2, 2015
Evaluation of discomfort and tolerability to bronchoscopy according to different sedation procedures with midazolamTakeshi Matsumoto, Kojiro Otsuka, Ryoji Kato, et al.
Respirology (Carlton, Vic.)|November 21, 2012
Serum procalcitonin is a valuable diagnostic marker in acute exacerbation of interstitial pneumoniaKazuma Nagata, Keisuke Tomii, Kojiro Otsuka, et al.
Anticancer Research|March 2, 2018
Reduced Tumour Proportion Scores for Programmed Cell Death Ligand 1 in Stored Paraffin Tissue SectionsYuki Sato, Daichi Fujimoto, Keiichiro Uehara, et al.
Plos One|December 23, 2016
Characteristics and Prognostic Impact of Pneumonitis during Systemic Anti-Cancer Therapy in Patients with Advanced Non-Small-Cell Lung CancerDaichi Fujimoto, Ryoji Kato, Takeshi Morimoto, et al.
Respiratory Investigation|June 26, 2025
Association between nonrestorative sleep status and sleep apnea syndrome: A cross-sectional and longitudinal study using health check-up and health insurance claims data in JapanNaomi Takahashi, Yoshimitsu Takahashi, Kimihiko Murase, et al.
Anticancer Research|October 28, 2015
Second-line Chemotherapy for Patients with Small Cell Lung Cancer and Interstitial Lung DiseaseDaichi Fujimoto, Ryoko Shimizu, Ryoji Kato, et al.
Clinical Lung Cancer|May 31, 2018
Programmed Cell Death Ligand 1 Expression in Non-Small-cell Lung Cancer Patients With Interstitial Lung Disease: A Matched Case-control StudyDaichi Fujimoto, Yuki Sato, Takeshi Morimoto, et al.
Cancer Chemotherapy and Pharmacology|September 24, 2014
The safety and efficacy of paclitaxel and carboplatin with or without bevacizumab for treating patients with advanced nonsquamous non-small cell lung cancer with interstitial lung diseaseRyoko Shimizu, Daichi Fujimoto, Ryoji Kato, et al.
Pageof 8